J Witte

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts

Fred C.G.J. Sweep, J Geurts-Moespot, Nicolai Grebenschikov et al. · British Journal of Cancer · 1998 · 121 citations

External Quality Assessment, Type 1, Breast Oncology +11

New classification of chronic GVHD: added clarity from the consensus diagnoses

Mukta Arora, S. Nagaraj, J Witte et al. · Bone Marrow Transplantation · 2008 · 86 citations

Disease Diagnosis, Chronic Gvhd, Consensus Diagnoses +5

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours

J Witte, John A. Foekens, Nils Brünner et al. · British Journal of Cancer · 2001 · 43 citations · Full text

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

J Witte, Fred C.G.J. Sweep, J.G.M. Klijn et al. · British Journal of Cancer · 1999 · 42 citations · Full text

Breast Oncology, Oncology, Cytosolic Tpa +14

Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients

J Witte, Fred C.G.J. Sweep, J.G.M. Klijn et al. · British Journal of Cancer · 1999 · 40 citations · Full text